Search

Neogen Corp

Suletud

SektorTervishoid

12.08 2.98

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

11.54

Max

12.11

Põhinäitajad

By Trading Economics

Sissetulek

-600K

-12M

Müük

-2.5M

223M

Aktsiakasum

0.07

Kasumimarginaal

-5.341

Töötajad

2,636

EBITDA

-8.8M

28M

Soovitused

By TipRanks

Soovitused

Osta

12 kuu keskmine prognoos

+19.35% upside

Dividendid

By Acuity

Järgmine tulemuste avaldamine

7. jaan 2027

Turustatistika

By TradingEconomics

Turukapital

-218M

2.6B

Eelmine avamishind

9.1

Eelmine sulgemishind

12.08

Neogen Corp Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

14. okt 2026, 22:56 UTC

Neogen Corp shares advanced in after-market trading, recovering from an initial dip amid notable volatility and positioning below its 20-day moving average.

13. okt 2026, 19:33 UTC

News

Investigation launched after FDA warning on veterinary product.

12. okt 2026, 22:11 UTC

Neogen Corp shares are declining in after-market trading, reversing from a brief positive position following three consecutive higher sessions.

9. okt 2026, 20:06 UTC

Neogen Corp's shares are advancing, recovering from earlier weakness.

8. okt 2026, 20:01 UTC

Neogen Corp shares are advancing, having peaked earlier in the session before pulling back, but remain significantly below their 20-day moving average.

7. okt 2026, 23:00 UTC

News

Neogen Corporation announced a growth strategy at its Investor Day, targeting $100 million in incremental revenue by FY2031, with shares trading lower in after-market hours.

6. okt 2026, 23:01 UTC

News
Social Media
Event

Neogen Corp reported Q1 revenue of $222.8 million, exceeding expectations, and raised FY 2027 revenue guidance, leading to a sharp rise in after-market hours trading.

5. okt 2026, 21:01 UTC

Neogen Corp's shares are higher in after-market hours, remaining above their 20-day moving average and positioned around the middle of their one-month range.

2. okt 2026, 23:05 UTC

Neogen Corp's shares rose in after-market trading, gaining ground following the close of regular trading and recovering from an initial peak.

1. okt 2026, 20:02 UTC

News

Neogen Corp shares fell sharply amid investigations into securities law violations related to its recalled product HYCOAT, following FDA findings linking it to fungal contamination.

30. sept 2026, 23:40 UTC

Neogen Corp is advancing in after-market trading, supported by a U.S. GDP growth revision to 2.2% and stronger-than-expected job growth in September.

29. sept 2026, 23:05 UTC

Neogen Corp shares are higher in after-market trading, reflecting routine activity, amid economic data showing declines in job openings and service sector contraction.

23. sept 2026, 20:07 UTC

Neogen Corp shares fell sharply Wednesday, reversing earlier gains and marking a notable departure from recent higher closes, though remaining above the 20-day moving average.

22. sept 2026, 20:01 UTC

Neogen Corp shares are trading higher, continuing an upward trajectory and remaining significantly above their 20-day moving average despite a slight retracement earlier in the day.

21. sept 2026, 20:02 UTC

Neogen Corp is trading sharply higher, continuing a trend of six consecutive sessions finishing higher and currently above its 20-day moving average.

18. sept 2026, 23:21 UTC

Neogen Corp is advancing in after-market trading, reflecting strong performance and remaining well above its 20-day moving average since Friday's close.

16. sept 2026, 20:06 UTC

Neogen Corp is advancing on Wednesday, continuing a trend higher since Tuesday's close, despite earlier pulling back from a session high.

14. sept 2026, 19:16 UTC

News

Neogen Corp shares are higher after analyst upgrades from Wall Street Zen and Piper Sandler, with quarterly earnings of $0.09 EPS exceeding expectations.

11. sept 2026, 21:01 UTC

Neogen Corp shares are trading higher in after-market hours, showing notable activity despite declining consumer sentiment as indicated by the Michigan Consumer Sentiment Index.

9. sept 2026, 20:07 UTC

Neogen Corp. shares are little changed amid broader market dynamics, including rising crude oil prices and speculation about potential interest rate hikes.

8. sept 2026, 19:36 UTC

News

Neogen Corp shares are higher as the company prepares for an Investor Day on October 7, 2026, focusing on strategic transformation and growth plans.

3. sept 2026, 19:46 UTC

Neogen Corp shares are lower in Thursday's session, exhibiting notable volatility after an initial rise. No specific news has been identified to explain the movement.

2. sept 2026, 20:08 UTC

Neogen Corp shares are advancing, driven by gains in the Health Care Supplies sub-sector. Earlier in the session, shares pulled back from a session high.

28. aug 2026, 20:08 UTC

Neogen Corp shares are lower today amid rising U.S. Treasury yields and inflation concerns, with fluctuations throughout the session.

26. aug 2026, 20:08 UTC

News
Social Media

Piper Sandler upgraded Neogen Corp to Overweight, raising its price target to $14. Shares are advancing during Wednesday's session despite earlier pullbacks.

25. aug 2026, 19:46 UTC

Neogen Corp's shares are higher today amid positive market sentiment, supported by declining crude oil prices and lower Treasury yields.

24. aug 2026, 19:36 UTC

Neogen Corp shares are declining today amid heightened market volatility linked to US sanctions against Iran and rising oil prices.

21. aug 2026, 21:01 UTC

Neogen Corp is gaining in after-market trading, continuing an increase since Friday's close. The stock remains above its 20-day moving average.

19. aug 2026, 20:02 UTC

Neogen Corp shares are higher during Wednesday's session, reflecting a broader market trend. The stock is above its 20-day moving average.

18. aug 2026, 19:36 UTC

Neogen Corp shares are lower today amid cautious market sentiment and rising treasury yields. The stock remains above its 20-day moving average.

Võrdlus sarnastega

Hinnamuutus

Neogen Corp Prognoos

Hinnasiht

By TipRanks

19.35% tõus

12 kuu keskmine prognoos

Keskmine 14 USD  19.35%

Kõrge 14 USD

Madal 14 USD

Põhineb 3 Wall Streeti analüütiku instrumendi Neogen Corp 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Osta

3 ratings

2

Osta

1

Hoia

0

Müü

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

$

Ettevõttest Neogen Corp

Neogen Corporation, together with its subsidiaries, engages in the development, manufacture, and marketing of various products and services dedicated to food and animal safety worldwide. It operates through two segments, Food Safety and Animal Safety. The Food Safety segment offers diagnostic test kits and related products to detect dangerous and unintended substances in food and animal feed, including foodborne pathogens, spoilage organisms, natural toxins, food allergens, ruminant by-products, meat speciation, drug residues, pesticide residues, and general sanitation concerns, as well as food quality and nutritional components. It also provides AccuPoint Advanced rapid sanitation test to detect the presence of adenosine triphosphate, a chemical found in living cells, as well as provides genomics-based diagnostic technology and software systems that help testers to objectively analyze and store their results and perform analysis on the results from multiple locations over extended periods. The segment offers its products primarily to milling and grain, meat and poultry, prepared food products and ingredients, fruits and vegetables, seafood, dairy, beverage, water, healthcare, traditional culture media markets, food service, and dietary supplements markets. The Animal Safety segment provides veterinary instruments, pharmaceuticals, vaccines, topicals, parasiticides, diagnostic products, rodent control products, cleaners, disinfectants, insect control products, and genomics testing services marketed through veterinarians, retailers, livestock producers, and animal health product distributors, for the animal safety market. The segment offers its products for companion animal veterinarians; livestock producers, veterinarians, and breed associations; retailers; breeding and genetics companies; diagnostic labs and universities; distributors; and other manufacturers and government agencies. The company was incorporated in 1981 and is headquartered in Lansing, Michigan.
help-icon Live chat